Announcement of TTY Biopharm's unaudited income information in March 2020
2020.4.14
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2020/04/14 | Time of announcement | 19:06:54 |
| Subject | Announcement of TTY Biopharm's unaudited income information in March 2020 | ||||
| Date of events | 2020/4/14 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2020/04/14 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $412,723 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $122,477 thousands, and a consolidated income before tax of $136,802 thousands in Mar 2020; net income attributed to stockholders of the company was $108,074 thousands; EPS is $0.43. Year-to-date consolidated net sales was $1,098,487 thousands (in NT dollars; unaudited), a consolidated operating profit was $285,672 thousands and consolidated income before tax was $327,139 thousands until Mar 2020; year-to-date net income attributed to stockholders of the company was $256,247 thousands; EPS is $1.03. 6.Countermeasures:N/A 7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||